@TumorBoardTues @JenniferLitton 1/18 #TumorBoardTuesday #BreastCancer #OncTwitter

32 yo 👩🏽
4 months post-partum
🚫comorbidities
FHx paternal uncle with #PanCan
🔬Bx: L breast mass - IDC, G3, ER 50%, PR 30%, HER2 0, Ki67 30%
Clinically node+; FNA confirms LN involvement
🚫 e/o metastatic dz

🤔Do all EXCEPT?

@TumorBoardTues @JenniferLitton 2/18 #TumorBoardTuesday #BCSM @JenniferLitton

🧬 testing returns with BRCA2 path variant
✂️ L mastectomy and ALND
Right risk ⬇️ mastectomy
Found to have 8+/15 LNs
Undergoes adjuvant AC/T

🤔After referring to ☢️ XRT, you discuss which of these treatments?

ET= AI+OS vs Tamoxifen

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret 3/18 #TumorBoardTuesday @MPishvaian @JohnEbbenMDPhD

👩🏻‍🏫 Mini tweetorial 1 👩🏼‍🏫

🧬Genetic testing

‼️EVERYONE w/ MBC or ⬆️risk EBC should have genetic testing‼️
Per @NCCN, pts with BC and:
🧬Age ≤ 50 y
🧬MBC
🧬⬆️risk HER2- EBC
🧬TNBC
🧬Male BC
🧬FMH, etc
📚nccn.org/professionals/…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN 4/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 2 👩🏼‍🏫

🧬Genetic testing cont’d

‼️All patients with MBC or ⬆️ risk early #BreastCancer ➡️ genetic testing‼️
Other guidelines ➡️ 🧬 testing for ALL pts w/ BC

📚@ASBrS breastsurgeons.org/docs/statement…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS 5/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 3👩🏼‍🏫

PARPi in pre-tx MBC with gBRCA1/2 mut
🔸OlympiAD: PFS 7.0 mo olaparib vs 4.2 mo chemo (HR 0.58)
🔸EMBRACA: PFS 8.6 mo talazoparib vs 5.6 mo chemo (HR 0.54)
⬆️Safety/QOL than chemo
📚nejm.org/doi/full/10.10…
📚nejm.org/doi/full/10.10…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS 6/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 4👩🏼‍🏫

✨OlympiA✨
🔸Ph III RCT, HER2-neg early BC with gBRCAm
🔸After standard NACT/adj chemo and local therapy
🔸Adjuvant olaparib x1 year vs placebo
🔸If HR+ s/p adjuvant chemo, must have ≥4 +LNs
📚@judygarber5 nejm.org/doi/full/10.10…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @hoperugo @drsarahsam @PTarantinoMD @s_santiesteban @TBlackburn25 @sdent_duke @sardesai_sagar @TNBCFoundation @DrLauraEsserman @AllisonKurian @RodriguezGIMD @yoichimuramoto @raalbany @Farah_Genetics

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @hoperugo @drsarahsam @PTarantinoMD @s_santiesteban @TBlackburn25 @sdent_duke @TNBCFoundation @DrLauraEsserman @AllisonKurian @RodriguezGIMD @yoichimuramoto @raalbany @Farah_Genetics 7/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 5👩🏼‍🏫

✨OlympiA✨

📍IDFS 85.9% olaparib vs 77.1% placebo (HR 0.58)
📍Subsequent 4-year OS found to be 90% olaparib vs 86% (HR 0.68)
📚pubmed.ncbi.nlm.nih.gov/36228963

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @hoperugo @drsarahsam @PTarantinoMD @s_santiesteban @TBlackburn25 @sdent_duke @TNBCFoundation @DrLauraEsserman @AllisonKurian @RodriguezGIMD @yoichimuramoto @raalbany @Farah_Genetics 8/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 6👩🏼‍🏫

✨MonarchE✨

🔸Ph III RCT, HR+ HER2-neg high-risk EBC
🔸After SOC NACT/adj chemo & local tx
🔸Pts with ≥4 +LNs OR
🔸1-3 LNs+ AND (size 5cm+, G3 OR Ki-67 ≥20%)
🔸SOC adjuvant ET +/- abemaciclib x2y
📚pubmed.ncbi.nlm.nih.gov/32954927/

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @hoperugo @drsarahsam @PTarantinoMD @s_santiesteban @TBlackburn25 @sdent_duke @TNBCFoundation 9/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 7👩🏼‍🏫

✨MonarchE✨

📍IDFS 2-year 92.2% abema vs 88.7% ET alone (HR 0.75)
📍IDFS 3-year 88.8% abema vs 83.4% ET alone (HR 0.696)
@professorSteph7 @TheLancetOncol @dr_yakupergun @ACaltavituro @drvineetagoel @EshaJ15 @Texastine @ecancer

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @hoperugo @drsarahsam @PTarantinoMD @s_santiesteban @TBlackburn25 @sdent_duke @TNBCFoundation @professorSteph7 @TheLancetOncol @dr_yakupergun 10/18 #TumorBoardTuesday #BreastCancer
👩🏻‍🏫 Mini tweetorial 8👩🏼‍🏫

✨MonarchE✨

🔸Ki-67 prognostic but 🚫 predictive of abema benefit
📚pubmed.ncbi.nlm.nih.gov/34656740/
🎉 03/03/23: @US_FDA removes prior requirement for Ki-67 ≥20%

@Yoko_T_ @ggabuin @educronemberger @FernandoOnco

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 @CharlesMilrod

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 11/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 9👩🏼‍🏫

📌Sequencing adjuvant tx

One possible schema by @JenniferLitton
🔸gBRCAwt HR+ ➡️ ET + abema
🔸gBRCAm HR+ ➡️ olaparib + ET; consider ET + abema after olaparib done
🔸gBRCAwt TNBC ➡️ capecitabine + IO
🔸gBRCAm TNBC ➡️ olaparib + IO

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 12/18 #TumorBoardTuesday
Back to our case🔎

32 yo 👩🏽 gBRCA2 mut high-risk EBC
S/p ✂️ surgery
☢️ adjuvant chemoradiation
💊 starts olaparib 300 mg BID + ET

👩🏽 interested in pregnancy 🤰🏽 after 5 years of ET
🧐 Asks about safety of pregnancy following #BreastCancer

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 13/18 #TumorBoardTuesday
👩🏻‍🏫 Mini tweetorial 10👩🏼‍🏫

📌Pregnancy after #BreastCancer

🔸< 5% new dx occurs in < 40yo
🔸Many young survivors desire pregnancy
🔸🤰🏽after BC does NOT worsen outcomes
🔸For 👩🏽 with HR+ dz, 🤰🏽 contraindicated during adj ET

📚ascopubs.org/doi/full/10.12…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 14/18 #TumorBoardTuesday

Is it safe to interrupt ET to attempt pregnancy?

✨POSITIVE✨
🔸International, prospective, single-arm trial
🔸Premenopausal 👩🏽 who desire pregnancy after BC
🔸≥18 mo & ≤30 mo of prior adj ET
🔸Stage I-III HR+ BC

@AnnPartridgeMD Presented at #SABCS22

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 @AnnPartridgeMD 15/18 #TumorBoardTuesday

✨POSITIVE✨

🔸compared to SOFT/TEXT cohort
📍43% age 35-39, 75% no prior births, 94% stage I or II
📍BCFI = time to 1st recurrence
📍Early results: 🚫 statistical difference
Suggest temporary 🛑 ET: attempt pregnancy 🚫 impact short-term outcomes

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 16/18 #TumorBoardTuesday #BCSM

Fertility discussions in cancer care 🎀

📌 Risk factors for permanent amenorrhea after chemo:
🔸⬆️age
🔸Ovarian reserve
🔸Chemo type & dose
🔸Duration of chemo
🔸ET (Tam)

📚pubmed.ncbi.nlm.nih.gov/23715580/
📚@ASCO ascopubs.org/doi/10.1200/jc…

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 17/18 #TumorBoardTuesday

Fertility preservation opts
🔸Embryo cryopreservation
🔸Oocyte cryopreserve
🔸Ovarian tissue cryopreserve (🚫in BRCA+)
🔸GnRH agonist during chemo
📚@matteolambe pubmed.ncbi.nlm.nih.gov/28453508/

🧐How do you approach discussions surrounding fertility in clinic?

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani @rafa_p10 @matteolambe 18/18 #TumorBoardTuesday #BCSM
Back to our case 🔎

🎉 #BreastCancer remains in remission, she finished adj ET
🤝 Through #SharedDecision 👩🏽 felt confident to attempt conception
🙏🏼 Will see patient in 6 months for follow up

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani #PostTest Q1️⃣ #TumorBoardTuesday
👉🏽#CME eval🔗 integrityce.com/TBTeval23
👉🏽ALL CME 🔗 integrityce.com/TBT2023

🤔@JenniferLitton @marijasullivan taught us tx’s BRCA+ #BreastCancer, test your 🧠 with quick Q’s

🧐What would you order
32yo 👩🏻‍🦱
Fmhx #PanCan
bx HR+/HER2- L breast
LN+

@TumorBoardTues @JenniferLitton @JasmineSukumar @Dr_RShatsky @awolff @jane_meisel @sardesai_sagar @andMORand @MassimoDiMaio75 @MLambouras @melindatelli @IBCradiation @TJH0828 @naborala @MuozMateu @FadwaARahman @emrekocamd @spinmaplered @LeandroJonatad1 @crisonco @adrianakahnmd @MamMa_mimumemo @LauBuisseret @MPishvaian @JohnEbbenMDPhD @NCCN @ASBrS @judygarber5 @stveep @DrKimAllison @ThanksCancer @curijoey @stolaney1 @prat_aleix @drteplinsky @DusoBruno @SBC_org @leah_minnie @LisaSingerMDPhD @DrTimothyErick @Icro_Meattini @Rick_Villalobos @BeverlyMoy @NiharikaDixit16 @hmcarthur @LubnaChaudhary1 @elmayermd @DrReshmaMahtani #PostTest Q2️⃣ #TumorBoardTuesday
👉🏽 Free CME eval🔗: integrityce.com/TBTeval23

🧐Which adjuvant therapy would you pick for
32yo👩🏼
🔬pathogenic gBRCA2+, HR+/HER2-, cN+ (8+) IDC
🤰🏼4-months postpartum
✂️surgery
💉adjuvant AC/T
☢️adjuvant XRT